<DOC>
	<DOCNO>NCT02695173</DOCNO>
	<brief_summary>The objective study compare , insulin use index date , sex-specific incidence hospitalization emergency department ( ED ) visit severe complication urinary tract infection ( UTI ) , define pyelonephritis urosepsis , among patient type 2 diabetes mellitus ( T2DM ) new user dapagliflozin new user antidiabetic drug ( ADs ) class sodium-glucose cotransporter 2 ( SGLT2 ) inhibitor , insulin monotherapy , metformin monotherapy , sulfonylurea monotherapy .</brief_summary>
	<brief_title>Complications UTI Patients Dapagliflozin</brief_title>
	<detailed_description>The overall goal research study estimate sex-specific incidence hospitalization emergency department visit severe complication urinary tract infection , define pyelonephritis urosepsis , patient prescribe dapagliflozin compare patient prescribe specific oral antidiabetic drug . Dapagliflozin antidiabetic drug use treat type 2 diabetes mellitus . Because mechanism action dapagliflozin result small safety monitoring study , interest evaluate safety dapagliflozin large population . The study implement three administrative health care data source two country : United Kingdom , Clinical Practice Research Datalink ( CPRD ) ; United States , Centers Medicare Medicaid Services ( CMS ) Medicare databases HealthCore Integrated Research Database ( HIRDSM ) . Individuals database include study meet follow age criterion ; 18 year old ( CPRD HIRD ) , 65 year old ( Medicare ) ; type 1 diabetes , new user one study drug meet criterion least 180 day electronic data first prescription study drug . The study period start July 1 , 2013 CPRD , January 1 , 2014 PHARMO January 9 , 2014 United States data source , end late available data database time analysis .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<criteria>1 . 18 year old ( CPRD HIRD ) , 65 year old ( Medicare ) ; 2. diagnosisi type 1 diabetes , 3. new user one study drug 4. least 180 day electronic data first prescription study drug 1 . The patient experience chronic pyelonephritis time index date ( i.e. , available lookback time ) . 2 . The patient prescribe SGLT2 inhibitor dapagliflozin index date . 3 . The patient initiate metformin sulfonylurea AD monotherapy index date . 4 . The patient initiated insulin therapy index date . 5 . The patient evidence type 1 diabetes cohort entry first record AD insulin monotherapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>